ICU Medical, Incorporated 

(Public, NASDAQ:ICUI)   Watch this stock   
Find more results for ICUI
Oct 19, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 19, 2009
Q3 2009 Earnings Release
Sep 23, 2009
UBS Global Life Sciences Conference
Sep 11, 2009
Sidoti Institutional Investor Forum
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 11.72% 11.87%
Operating margin 14.15% 17.28%
EBITD margin - 24.22%
Return on average assets 8.32% 9.24%
Return on average equity 9.30% 10.41%
Employees 1,829 -

Address

951 Calle Amanecer
San Clemente, CA 92673
United States - Map
+1-949-3662183 (Phone)
+1-949-3668368 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

ICU Medical, Incorporated discussed on blogs

ICU Medical, Incorporated discussions

  View all discussions »

Description

ICU Medical, Inc. is engaged in the development, manufacture and sale of disposable medical connection systems for use in vascular therapy applications. The Company’s devices are designed to protect patients from catheter-related bloodstream infections and healthcare workers from exposure to infectious diseases through accidental needlesticks. It is also engaged in the production of custom intravenous (I.V.) systems, critical care medical devices, including catheters, angiography kits and cardiac monitoring systems. The Company designed CLAVE to eliminate needles from certain applications in acute care hospitals, home healthcare, ambulatory surgical centers, nursing homes, convalescent facilities, physician’s offices, medical clinics, and emergency centers. The principal products that it has introduced include Spiros Closed Male Connector, Genie Closed Vial Access Device and a line of custom I.V. therapy sets designed for use in Oncology.

Officers and directors

George A. Lopez M.D.
Chairman of the Board, President, Chief Executive Officer
Age: 61
Bio & Compensation - Reuters
Scott E. Lamb
Chief Financial Officer
Age: 46
Bio & Compensation - Reuters
Steven C. Riggs
Vice President - Operations
Age: 49
Bio & Compensation - Reuters
Richard A. Costello
Vice President - Sales
Age: 45
Bio & Compensation - Reuters
Alison D. Burcar
Vice President - Product Development
Age: 36
Bio & Compensation - Reuters
Jack W. Brown
Director
Age: 69
Bio & Compensation - Reuters
John J. Connors Esq.
Director
Age: 69
Bio & Compensation - Reuters
Michael T. Kovalchik III, M.D.
Director
Age: 63
Bio & Compensation - Reuters
Richard H. Sherman M.D.
Director
Age: 62
Bio & Compensation - Reuters
Robert S. Swinney M.D.
Director
Age: 63
Bio & Compensation - Reuters